121 related articles for article (PubMed ID: 38593621)
21. Tubulin acetylation promoting potency and absorption efficacy of deacetylase inhibitors.
Mangas-Sanjuan V; Oláh J; Gonzalez-Alvarez I; Lehotzky A; Tőkési N; Bermejo M; Ovádi J
Br J Pharmacol; 2015 Feb; 172(3):829-40. PubMed ID: 25257800
[TBL] [Abstract][Full Text] [Related]
22. Dysferlin interacts with histone deacetylase 6 and increases alpha-tubulin acetylation.
Di Fulvio S; Azakir BA; Therrien C; Sinnreich M
PLoS One; 2011; 6(12):e28563. PubMed ID: 22174839
[TBL] [Abstract][Full Text] [Related]
23. HDAC6 α-tubulin deacetylase: a potential therapeutic target in neurodegenerative diseases.
Li G; Jiang H; Chang M; Xie H; Hu L
J Neurol Sci; 2011 May; 304(1-2):1-8. PubMed ID: 21377170
[TBL] [Abstract][Full Text] [Related]
24. Acetylated α-tubulin K394 regulates microtubule stability to shape the growth of axon terminals.
Saunders HAJ; Johnson-Schlitz DM; Jenkins BV; Volkert PJ; Yang SZ; Wildonger J
Curr Biol; 2022 Feb; 32(3):614-630.e5. PubMed ID: 35081332
[TBL] [Abstract][Full Text] [Related]
25. Tubulin hyperacetylation is adaptive in cardiac proteotoxicity by promoting autophagy.
McLendon PM; Ferguson BS; Osinska H; Bhuiyan MS; James J; McKinsey TA; Robbins J
Proc Natl Acad Sci U S A; 2014 Dec; 111(48):E5178-86. PubMed ID: 25404307
[TBL] [Abstract][Full Text] [Related]
26. Histone deacetylase inhibitors that target tubulin.
Schemies J; Sippl W; Jung M
Cancer Lett; 2009 Aug; 280(2):222-32. PubMed ID: 19268440
[TBL] [Abstract][Full Text] [Related]
27. Neural deficits in a mouse model of PACS1 syndrome are corrected with PACS1- or HDAC6-targeting therapy.
Villar-Pazos S; Thomas L; Yang Y; Chen K; Lyles JB; Deitch BJ; Ochaba J; Ling K; Powers B; Gingras S; Kordasiewicz HB; Grubisha MJ; Huang YH; Thomas G
Nat Commun; 2023 Oct; 14(1):6547. PubMed ID: 37848409
[TBL] [Abstract][Full Text] [Related]
28. Activation of histone deacetylase-6 induces contractile dysfunction through derailment of α-tubulin proteostasis in experimental and human atrial fibrillation.
Zhang D; Wu CT; Qi X; Meijering RA; Hoogstra-Berends F; Tadevosyan A; Cubukcuoglu Deniz G; Durdu S; Akar AR; Sibon OC; Nattel S; Henning RH; Brundel BJ
Circulation; 2014 Jan; 129(3):346-58. PubMed ID: 24146251
[TBL] [Abstract][Full Text] [Related]
29. Structural insights into HDAC6 tubulin deacetylation and its selective inhibition.
Miyake Y; Keusch JJ; Wang L; Saito M; Hess D; Wang X; Melancon BJ; Helquist P; Gut H; Matthias P
Nat Chem Biol; 2016 Sep; 12(9):748-54. PubMed ID: 27454931
[TBL] [Abstract][Full Text] [Related]
30. Modification of cardiac disease by transgenically altered histone deacetylase 6.
Sanbe A; Inomata Y; Matsushita N; Sawa Y; Hino C; Yamazaki H; Takanohashi K; Takahashi N; Higashio R; Tsumura H; Aoyagi T; Hirose M
Biochem Biophys Res Commun; 2022 Nov; 631():48-54. PubMed ID: 36166953
[TBL] [Abstract][Full Text] [Related]
31. The synergistic combination of the farnesyl transferase inhibitor lonafarnib and paclitaxel enhances tubulin acetylation and requires a functional tubulin deacetylase.
Marcus AI; Zhou J; O'Brate A; Hamel E; Wong J; Nivens M; El-Naggar A; Yao TP; Khuri FR; Giannakakou P
Cancer Res; 2005 May; 65(9):3883-93. PubMed ID: 15867388
[TBL] [Abstract][Full Text] [Related]
32. HDAC6 is a microtubule-associated deacetylase.
Hubbert C; Guardiola A; Shao R; Kawaguchi Y; Ito A; Nixon A; Yoshida M; Wang XF; Yao TP
Nature; 2002 May; 417(6887):455-8. PubMed ID: 12024216
[TBL] [Abstract][Full Text] [Related]
33. Novel HDAC6 Inhibitors Increase Tubulin Acetylation and Rescue Axonal Transport of Mitochondria in a Model of Charcot-Marie-Tooth Type 2F.
Adalbert R; Kaieda A; Antoniou C; Loreto A; Yang X; Gilley J; Hoshino T; Uga K; Makhija MT; Coleman MP
ACS Chem Neurosci; 2020 Feb; 11(3):258-267. PubMed ID: 31845794
[TBL] [Abstract][Full Text] [Related]
34. Overexpressed HDAC8 in cervical cancer cells shows functional redundancy of tubulin deacetylation with HDAC6.
Vanaja GR; Ramulu HG; Kalle AM
Cell Commun Signal; 2018 May; 16(1):20. PubMed ID: 29716651
[TBL] [Abstract][Full Text] [Related]
35. Decreased α-tubulin acetylation induced by an acidic environment impairs autophagosome formation and leads to rat cardiomyocyte injury.
Yang L; Zhao L; Cui L; Huang Y; Ye J; Zhang Q; Jiang X; Zhang D; Huang Y
J Mol Cell Cardiol; 2019 Feb; 127():143-153. PubMed ID: 30582931
[TBL] [Abstract][Full Text] [Related]
36. Tubulin acetylation: responsible enzymes, biological functions and human diseases.
Li L; Yang XJ
Cell Mol Life Sci; 2015 Nov; 72(22):4237-55. PubMed ID: 26227334
[TBL] [Abstract][Full Text] [Related]
37. HDAC6 inhibition promotes α-tubulin acetylation and ameliorates CMT2A peripheral neuropathy in mice.
Picci C; Wong VSC; Costa CJ; McKinnon MC; Goldberg DC; Swift M; Alam NM; Prusky GT; Shen S; Kozikowski AP; Willis DE; Langley B
Exp Neurol; 2020 Jun; 328():113281. PubMed ID: 32147437
[TBL] [Abstract][Full Text] [Related]
38. SIRT2 inactivation reveals a subset of hyperacetylated perinuclear microtubules inaccessible to HDAC6.
Skoge RH; Ziegler M
J Cell Sci; 2016 Aug; 129(15):2972-82. PubMed ID: 27311481
[TBL] [Abstract][Full Text] [Related]
39. Carbamazepine promotes Her-2 protein degradation in breast cancer cells by modulating HDAC6 activity and acetylation of Hsp90.
Meng Q; Chen X; Sun L; Zhao C; Sui G; Cai L
Mol Cell Biochem; 2011 Feb; 348(1-2):165-71. PubMed ID: 21082217
[TBL] [Abstract][Full Text] [Related]
40. C6-ceramide synergistically potentiates the anti-tumor effects of histone deacetylase inhibitors via AKT dephosphorylation and α-tubulin hyperacetylation both in vitro and in vivo.
Zhu QY; Wang Z; Ji C; Cheng L; Yang YL; Ren J; Jin YH; Wang QJ; Gu XJ; Bi ZG; Hu G; Yang Y
Cell Death Dis; 2011 Jan; 2(1):e117. PubMed ID: 21368888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
